Ipca Laboratories Ltd. Financials

NSE BSE

15:59 Sep 12

Ipca Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

1314.80

+2.60 (+0.20%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

1314.80

+2.60 (+0.20%)
15:59 Sep 12

Quality

98/100
High Financial Strength

Valuation

41/100
Mid Valuation

Technical

36/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM 2025
Net Sales	5829.79	6244.32	7705.04	8939.59	9155.81
Operating Expenses +	4520.53	5317.55	6383.88	7213.45	7405.97
Raw Material	2144.5	2205.84	2706.39	2824.6	2904.44
Increase Decrease in Cost	-129.65	100.67	-130.64	-46.05	-77.82
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	1177.39	1287.64	1708.43	1983.99	2039.29
Miscellaneous Expenses	2288.89	2717.78	3079.84	3546.47	2540.06
Operating Profit	1309.26	926.77	1321.16	1726.14	1749.84
Other Income	66.57	125.62	124.77	92.8	104.85
Depreciation	232.42	261.56	357.24	397.82	398.99
Interest	7.69	45.54	138.27	84.93	79.39
Profit before tax and exceptio..	1135.72	745.29	950.42	1336.19	1376.31
Exceptional Items	0	0	-107.75	-205.05	-205.05
PBT	1135.72	745.29	842.67	1131.14	1581.36
Provision for Taxation	224.77	253.36	313.46	343.61	348.29
Net Profit	910.95	491.93	529.21	787.53	822.97
NET Profit after MI	884.08	471.32	547.35	737.68	778.65
EPS	34.85	18.58	21.57	29.08	30.69
Operating Profit Margin (%)	22.46	14.84	17.15	19.31	19.11
Net Profit Margin (%)	15.16	7.55	7.1	8.25	8.5

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	44.70	44.70	44.70	46.30	46.30
FII	10.70	10.80	11.10	10.80	10.80
MF	29.60	29.60	29.60	28.60	28.50
Others	6.60	6.40	6.00	5.60	5.30

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: